BSE Live
Jan 20, 14:28Prev. Close
4079.15
Open Price
4052.05
Bid Price (Qty.)
4056.10 (1)
Offer Price (Qty.)
4071.85 (1)
NSE Live
Jan 20, 14:28Prev. Close
4074.50
Open Price
4074.50
Bid Price (Qty.)
4063.50 (5)
Offer Price (Qty.)
4067.40 (1)
| Key Financial Ratios of Sanofi India (in Rs. Cr.) | Dec 19 | Dec 18 | Dec 17 | Dec 16 | Dec 15 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 179.85 | 165.48 | 141.74 | 129.13 | 139.59 | |
| Diluted EPS (Rs.) | 179.85 | 165.48 | 141.74 | 129.13 | 139.59 | |
| Cash EPS (Rs.) | 223.52 | 210.13 | 186.17 | 186.22 | 188.68 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 1,061.87 | 964.87 | 881.04 | 754.48 | 706.43 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 1,061.87 | 964.87 | 881.04 | 754.61 | 706.54 | |
| Dividend / Share(Rs.) | 349.00 | 84.00 | 71.00 | 68.00 | 65.00 | |
| Revenue from Operations/Share (Rs.) | 1,335.04 | 1,204.70 | 1,083.22 | 1,029.83 | 952.25 | |
| PBDIT/Share (Rs.) | 330.17 | 310.09 | 268.65 | 260.39 | 221.63 | |
| PBIT/Share (Rs.) | 286.74 | 265.43 | 224.22 | 203.30 | 172.55 | |
| PBT/Share (Rs.) | 260.83 | 265.13 | 223.74 | 202.65 | 208.80 | |
| Net Profit/Share (Rs.) | 180.09 | 165.48 | 141.74 | 129.13 | 139.60 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 24.73 | 25.73 | 24.80 | 25.28 | 23.27 | |
| PBIT Margin (%) | 21.47 | 22.03 | 20.69 | 19.74 | 18.12 | |
| PBT Margin (%) | 19.53 | 22.00 | 20.65 | 19.67 | 21.92 | |
| Net Profit Margin (%) | 13.48 | 13.73 | 13.08 | 12.53 | 14.65 | |
| Return on Networth / Equity (%) | 16.95 | 17.15 | 16.08 | 17.11 | 19.76 | |
| Return on Capital Employed (%) | 25.95 | 25.86 | 23.69 | 15.86 | 17.98 | |
| Return on Assets (%) | 12.76 | 12.75 | 11.73 | 11.69 | 13.36 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 94.64 | 92.85 | 89.69 | 93.25 | 91.20 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 3.03 | 2.55 | 2.40 | 2.35 | 2.02 | |
| Quick Ratio (X) | 2.36 | 1.78 | 1.71 | 1.61 | 1.24 | |
| Inventory Turnover Ratio (X) | 6.54 | 5.74 | 5.99 | 4.80 | 4.58 | |
| Dividend Payout Ratio (NP) (%) | 36.69 | 42.98 | 48.06 | 52.76 | 46.56 | |
| Dividend Payout Ratio (CP) (%) | 29.56 | 33.85 | 36.59 | 36.58 | 34.45 | |
| Earnings Retention Ratio (%) | 63.31 | 57.02 | 51.94 | 47.24 | 53.44 | |
| Cash Earnings Retention Ratio (%) | 70.44 | 66.15 | 63.41 | 63.42 | 65.55 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 15,006.27 | 13,779.31 | 10,113.22 | 9,324.14 | 9,464.39 | |
| EV/Net Operating Revenue (X) | 4.89 | 4.97 | 4.06 | 3.94 | 4.32 | |
| EV/EBITDA (X) | 19.76 | 19.32 | 16.37 | 15.57 | 18.54 | |
| MarketCap/Net Operating Revenue (X) | 5.25 | 5.27 | 4.35 | 4.17 | 4.58 | |
| Retention Ratios (%) | 63.30 | 57.01 | 51.93 | 47.23 | 53.43 | |
| Price/BV (X) | 6.61 | 6.58 | 5.35 | 5.70 | 6.17 | |
| Price/Net Operating Revenue | 5.25 | 5.27 | 4.35 | 4.17 | 4.58 | |
| Earnings Yield | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
01.08.2025
16.07.2025
Emcure Pharma announces deal with Sanofi India to distribute oral anti-diabetic products in India
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
17.03.2025
Sanofi India Consolidated December 2024 Net Sales at Rs 514.90 crore, down 25.8% Y-o-Y
29.07.2024
Sanofi India Consolidated June 2024 Net Sales at Rs 463.50 crore, down 34.36% Y-o-Y